Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load

Published: 3 October 2025| Version 1 | DOI: 10.17632/9kx8hc6h66.1
Contributors:
, Cathelijne Fokkema,

Description

This dataset includes feature count matrices, cellular barcodes of tumor plasma cells, and RDS files containing processed single-cell RNA sequencing (scRNA-seq) data. The data were generated and analyzed as part of the study by Fokkema, Bertamini et al. (in review, 2025), focusing on the transcriptional landscape of bone marrow and circulating myeloma plasma cells.

Files

Steps to reproduce

Steps to reproduce the data can be found in https://github.com/MyelomaRotterdam/Fokkema-Bertamini-et-al.2025-

Institutions

  • Erasmus MC

Categories

Multiple Myeloma, Single-Cell RNA Sequencing

Licence